Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience

The international Linked Clinical Trials (iLCT) program for Parkinson’s to date represents one of the most comprehensive drug repurposing programs focused on one disease. Since initial planning in 2010, it has rapidly grown – giving rise to seven completed, and 15 ongoing, clinical trials of 16 agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Stott, Simon R. W., Wyse, Richard K., Brundin, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017145/
https://www.ncbi.nlm.nih.gov/pubmed/33815053
http://dx.doi.org/10.3389/fnins.2021.653377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017145/
https://www.ncbi.nlm.nih.gov/pubmed/33815053
http://dx.doi.org/10.3389/fnins.2021.653377

Ejemplares similares